secwatch.observer — SEC 8-K summary
======================================

Issuer:     TriSalus Life Sciences, Inc. (TLSI)
CIK:        0001826667
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001104659-24-057985
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

TriSalus Life Sciences appoints Liselotte Hyveled to Board, effective May 6
---------------------------------------------------------------------------

- Board size increased to ten directors; Hyveled appointed as Class I director, term expiring at 2024 annual meeting.
- Annual cash retainer of $50,000 for Board service; grant of option to purchase 35,000 shares vesting over three years.
- Additional $7,500 annual retainer for each of Nominating Committee and Science & Technology Committee membership.
- No arrangements or transactions requiring disclosure under Item 404(a); standard indemnity agreement entered.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924057985/0001104659-24-057985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1826667/000110465924057985/tm2413673d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-057985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer